Autosomal recessive spastic paraplegia type 70

Autosomal recessive spastic paraplegia type 70 (SPG70) is a very rare inherited neurological condition that primarily affects the nerves controlling leg movement. It belongs to a group of disorders called hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness (spasticity) and weakness in the legs. In SPG70, the disease typically begins in childhood and gradually worsens over time. People with SPG70 experience increasing difficulty walking due to stiffness and weakness in the lower limbs. The condition may also be associated with additional neurological features, including intellectual disability, speech difficulties, and problems with coordination. Some individuals may develop issues with bladder control as the disease progresses. The severity of symptoms can vary between affected individuals, even within the same family. Currently, there is no cure for SPG70. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, stretching exercises, and medications to reduce muscle stiffness (such as baclofen or tizanidine) are commonly used. Assistive devices like braces, walkers, or wheelchairs may become necessary as mobility declines. A multidisciplinary care team involving neurologists, physical therapists, and other specialists is important for comprehensive management.

Bring these to your next appointment

• Q1.How quickly is this condition likely to progress in my child's case?,What therapies are most important to start right away?,Are there any medications that can help with the leg stiffness?,Should we consider genetic counseling for our family?,What school accommodations should we request?,Are there any clinical trials or research studies we could participate in?,How often should we schedule follow-up appointments with the neurology team?

Common questions about Autosomal recessive spastic paraplegia type 70